On the other hand, three targets in the renin-angiotensin system that have been extensively studied in the preclinical and clinical studies for the treatment of hypertension with vaccines include: renin, angiotensin I, and angiotensin II and its receptors. The gene discussed is AGT; the disease is Hypertension.